We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02542514
Brief Title: Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma (iLOC)

First Submitted : August 31, 2015
First Submitted that Met QC Criteria : September 4, 2015
First Posted : September 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 6, 2022
Last Update Posted : April 14, 2022